Top compounds associated with response to CTD-3105H18.16


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.00036 1
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC -0.00027 1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.00011 1
mRNA GW-405833 CTRPv2 pan-cancer AAC -0.0001 1
Download CSV